UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000056989 |
|---|---|
| Receipt number | R000065117 |
| Scientific Title | Development of educational content for promotion of HPV health literacy among young adult males |
| Date of disclosure of the study information | 2025/03/25 |
| Last modified on | 2025/08/15 09:21:25 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Verification of the effectiveness of educational content to promote HPV vaccination among young adult males
Acronym
A study of HPV vaccination promotion
Scientific Title
Development of educational content for promotion of HPV health literacy among young adult males
Scientific Title:Acronym
Development of educational content for promotion of HPV health literacy among young adult males
Region
| Japan |
Condition
Condition
Not applicicable
Classification by specialty
| Not applicable | Adult |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
Verification of the effectiveness of educational content in increasing young adult males' interest in HPV vaccination their willingness to be vaccinated
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
vaccination intention
Key secondary outcomes
e Health Literacy
Health Locus of Control
Vaccination Readiness
Willingness to pay
Knowledge of HPV vaccine
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Individual
Blinding
Open -no one is blinded
Control
No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
2
Purpose of intervention
Educational,Counseling,Training
Type of intervention
| Other |
Interventions/Control_1
A video about the HPV vaccine
Interventions/Control_2
A leaflet about the HPV vaccine
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| 26 | years-old | >= |
Gender
Male
Key inclusion criteria
Japanese male between the ages of 18-26 years
Key exclusion criteria
Individuals medically contraindicated to vaccinate
Target sample size
800
Research contact person
Name of lead principal investigator
| 1st name | Hiroko |
| Middle name | |
| Last name | Watanabe |
Organization
University of Osaka Graduate School of Medicine
Division name
Division of Health Science
Zip code
565-0871
Address
1-7 Yamadaoka, Suita, Osaka
TEL
06-6879-2520
watanabe@sahs.med.osaka-u.ac.jp
Public contact
Name of contact person
| 1st name | Hiroko |
| Middle name | |
| Last name | Watanabe |
Organization
University of Osaka Graduate School of Medicine
Division name
Division of Health Science
Zip code
565-0871
Address
1-7 Yamadaoka, Suita, Osaka
TEL
06-6879-2520
Homepage URL
watanabe@sahs.med.osaka-u.ac.jp
Sponsor or person
Institute
University of Osaka
Institute
Department
Personal name
Funding Source
Organization
Japan Science and Technology Agency
Organization
Division
Category of Funding Organization
Japanese Governmental office
Nationality of Funding Organization
Other related organizations
Co-sponsor
Kobe University, Osaka General Medical Center
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Institutional Review Board of Osaka University Hospital
Address
2-2 Yamadaoka, Suita, Osaka
Tel
06-6210-8296
rinri@hp-crc.med.osaka-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2025 | Year | 03 | Month | 25 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2025 | Year | 02 | Month | 09 | Day |
Date of IRB
| 2025 | Year | 04 | Month | 14 | Day |
Anticipated trial start date
| 2025 | Year | 05 | Month | 08 | Day |
Last follow-up date
| 2025 | Year | 05 | Month | 14 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2025 | Year | 02 | Month | 10 | Day |
Last modified on
| 2025 | Year | 08 | Month | 15 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000065117
